The role of epigenetic regulation in pancreatic ductal adenocarcinoma progression and drug response: an integrative genomic and pharmacological prognostic prediction model
BackgroundPancreatic ductal adenocarcinoma (PDAC) is a highly lethal malignancy with poor prognosis. Epigenetic dysregulation plays a crucial role in PDAC progression, but its comprehensive landscape and clinical implications remain unclear.MethodsWe integrated single-cell RNA sequencing, bulk RNA s...
Saved in:
Main Authors: | Kang Fu (Author), Junzhe Su (Author), Yiming Zhou (Author), Xiaotong Chen (Author), Xiao Hu (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2024-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Ion Channels Orchestrate Pancreatic Ductal Adenocarcinoma Progression and Therapy
by: Verena Hofschröer, et al.
Published: (2021) -
HOXA9 and CD163 potentiate pancreatic ductal adenocarcinoma progression
by: Aiat Shaban Hemida, et al.
Published: (2024) -
Targeting hyaluronan for the treatment of pancreatic ductal adenocarcinoma
by: Norihiro Sato, et al.
Published: (2016) -
Surgical Treatment of Pancreatic Ductal Adenocarcinoma
Published: (2021) -
Do the Well Known Prognostic Parameters in Pancreatic Ductal Adenocarcinoma Really Reflect Survival?
by: Sonay KUŞ ÖZTÜRK, et al.
Published: (2018)